Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Fallopian Tube High Grade Serous Adenocarcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm
Serous Neoplasm
Fallopian Tube Serous Neoplasm
Fallopian Tube Serous Adenocarcinoma
Fallopian Tube High Grade Serous Adenocarcinoma

Subtype

Fallopian Tube High Grade Serous Adenocarcinoma

CI-CAN-00007694Explore in graph →

15 active trials

NCIt: C126456

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials21
Research
Rankings
Sources & provenance

Data completeness1 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (no data yet)
Genomics (no data yet)
Evidence (no data yet)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A rapidly growing serous adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of high-grade cytologic features and frequent mitotic figures.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Fallopian Tube Serous AdenocarcinomaSubtype
High Grade Serous AdenocarcinomaHistology

Children (2)

ncit

Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma
Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma

Anatomy

Anatomical sites

AdnexalC212119
Genitourinary SystemC156482

Record

Identity

CancerIndex ID: CI-CAN-00007694
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 7
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active): 21 / 15

Publications (all / 5y)

0 / 0

Evidence items

0

Genes / variants

0 / 0

Drugs (any / approved)

0 / 0

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 19 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (2)

High Grade Fallopian Tube Serous Adenocarcinomasynonym · NCIt
High Grade Fallopian Tube Serous Carcinomasynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials15countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #501 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials4countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #633 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items0countaccepted CIViC items · entity + descendantscivicComputednot in a current ranking snapshot
Publications, last 12 months0countPubMed records · stored query · 12-month windowpubmedComputednot in a current ranking snapshot
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 19 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants